Colostrum for Immune Function

Verdict: Weak, subgroup-only evidence for immune benefit

Bovine colostrum shows a modest signal for reducing upper-respiratory infections in heavily-stressed or high-exposure groups (athletes, exposed students, young children), but it does not reliably move immune blood markers and is not a proven immune booster for healthy adults. Major regulators and clinics do not endorse it for immune function.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

The grade is Weak Evidence (Tier C) because the clinical and biological data point in different directions. Two meta-analyses found fewer upper-respiratory infections with colostrum: a 2016 analysis in exercising adults (PMID 27462401, n=152) reported 44% fewer symptom-days and 38% fewer episodes, and a 2022 analysis (PMID 37111143, n=445, 7 trials) found a risk ratio of 0.64. But 4 of 5 trials in the 2016 review were at moderate-to-high risk of bias, keeping confidence limited.

Crucially, a 2020 meta-analysis of immune blood markers (PMID 32276466, n=239, industry-funded by Nutricia) found little to no effect on serum IgA, IgG, lymphocytes or neutrophils, so the mechanism behind any benefit is unclear. The clinical effect also appears confined to specific groups: a 2023 trial (PMID 37111143, n=158) helped only the high-exposure medical-student subgroup, and a positive pediatric trial (PMID 37630816) was very small (n=57). Generalizing to ordinary healthy adults is not supported.

Regulators and clinics reinforce the cautious grade rather than overturn it. The US FDA treats disease-claim colostrum products as unapproved new drugs that are not generally recognized as safe and effective, the EU's EFSA rejected colostrum immune-defence claims as having no established cause-and-effect, and WHO/WADA flag trace IGF-1 for athletes. Cleveland Clinic advises against it, and Mayo Clinic notes benefits mostly in elite athletes. Net result: a real but narrow, low-certainty signal, not a broad immune cure.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.46
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
81%
Highly consistent evidence
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.35
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L11 AI re-checkIndependent read
0.50
L1 ExamineGlobal benchmark
0.70
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.455
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (5)L2 · primary research & systematic reviews

Bovine colostrum supplementation and upper respiratory symptoms during exercise training: a systematic review and meta-analysis of randomised controlled trials
PMID: 27462401 2016 統合分析 n = 152
Finding: BC reduced URS days by 44% (rate ratio 0.56, 95% CI 0.43–0.72, p<0.001) and URS episodes by 38% (0.62, 95% CI 0.40–0.99, p=0.04) vs placebo in exercising adults; 4 of 5 studies judged moderate/high risk of bias.
Effect size: RR URS days 0.56; RR URS episodes 0.62
View on PubMed
Immunological Outcomes of Bovine Colostrum Supplementation in Trained and Physically Active People: A Systematic Review and Meta-Analysis
PMID: 32276466 2020 統合分析 n = 239
Finding: BC showed no or a fairly low impact on improving concentration of serum immunoglobulins (IgA, IgG), lymphocytes and neutrophils; heterogeneous responses in salivary IgA (I² 0–85.47%); authors note a gap in mechanistic understanding.
Mixed funding Effect size: Largely null on immunological biomarkers
View on PubMed
Moderate Dose Bovine Colostrum Supplementation in Prevention of Upper Respiratory Tract Infections in Medical University Students: A Randomized, Triple Blind, Placebo-Controlled Trial
PMID: 37111143 2022 統合分析 n = 445
Finding: Medical students (high-exposure subgroup) showed significant reduction in URTI frequency (p=0.002) and severity (p=0.035); health science students (lower exposure) showed no benefit. Effect limited to high-risk subgroup.
Effect size: Subgroup-dependent; no effect in general population
View on PubMed
Moderate Dose Bovine Colostrum Supplementation in Prevention of Upper Respiratory Tract Infections in Medical University Students: A Randomized, Triple Blind, Placebo-Controlled Trial
PMID: 37111143 2023 隨機對照試驗 n = 158
Finding: Medical students (high-exposure subgroup) showed significant reduction in URTI frequency (p=0.002) and severity (p=0.035); health science students (lower exposure) showed no benefit. Effect limited to high-risk subgroup.
Effect size: Subgroup-dependent; no effect in general population
View on PubMed
Six Weeks of Supplementation with Bovine Colostrum Effectively Reduces URTIs Symptoms Frequency and Gravity for Up to 20 Weeks in Pre-School Children
PMID: 37630816 2023 隨機對照試驗 n = 57
Finding: 31% median reduction in symptomatic days by week 20 (p=0.047); 37% median reduction in symptom severity (p=0.041); 50% reduction in moderate-severity episodes (p=0.025). Small sample (n=57).
🟠 Limited quality Effect size: FSD −31%; AGS −37%
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
Your Colostrum-LD products are not generally recognized as safe and effective for the above referenced uses and, therefore, the products are 'new drugs' under section 201(p) of the FD&C Act, 21 U.S.C. 321(p). source↗
L4b EU EFSA
Against
L4d TW TFDA / 衛福部
Neutral
牛乳及其製品(含初乳)屬於傳統食品。 source↗
L4e WHO
Cautious
very small quantities of IGF-1 can be found naturally in animal products (e.g. colostrums, deer antler velvet). source↗
L5b Mayo Clinic
Neutral
Recent research shows some success with curbing acute diarrhea and preventing seasonal respiratory infections. The current research mostly supports immune benefits only in elite athletes. source↗
L5c Cleveland Clinic
Against
L5e Specialty Society (condition-mapped)
Not addressed
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬5 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-immune-function-INT-colostrum-001 繁體中文版 →